Two drug molecules achieve myelin repair in MS disease models

BY THE OPTIMIST DAILY EDITORIAL TEAM

Every remyelination drug candidate tested in multiple sclerosis research has failed. A doctoral thesis from the University of Helsinki, defended earlier this month, reports two that didn’t.

Tapani Koppinen, working in Associate Professor Merja…

Click here to view the original article.